182 related articles for article (PubMed ID: 35761402)
1. A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge.
Park JE; Kim JH; Park JY; Jun SH; Shin HJ
Virol J; 2022 Jun; 19(1):112. PubMed ID: 35761402
[TBL] [Abstract][Full Text] [Related]
2. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B
mBio; 2020 Apr; 11(2):. PubMed ID: 32265331
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
4. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L
Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102
[TBL] [Abstract][Full Text] [Related]
5. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.
Wang C; Zheng X; Gai W; Zhao Y; Wang H; Wang H; Feng N; Chi H; Qiu B; Li N; Wang T; Gao Y; Yang S; Xia X
Oncotarget; 2017 Feb; 8(8):12686-12694. PubMed ID: 27050368
[TBL] [Abstract][Full Text] [Related]
6. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
7. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
[TBL] [Abstract][Full Text] [Related]
8. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
9. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.
Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241
[TBL] [Abstract][Full Text] [Related]
10. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
[TBL] [Abstract][Full Text] [Related]
11. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH
Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720
[TBL] [Abstract][Full Text] [Related]
12. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
[TBL] [Abstract][Full Text] [Related]
13. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
[TBL] [Abstract][Full Text] [Related]
14. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
Kato T; Takami Y; Kumar Deo V; Park EY
J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
[TBL] [Abstract][Full Text] [Related]
15. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.
Wang C; Zheng X; Gai W; Wong G; Wang H; Jin H; Feng N; Zhao Y; Zhang W; Li N; Zhao G; Li J; Yan J; Gao Y; Hu G; Yang S; Xia X
Antiviral Res; 2017 Apr; 140():55-61. PubMed ID: 28040513
[TBL] [Abstract][Full Text] [Related]
16. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L
Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605
[TBL] [Abstract][Full Text] [Related]
17. Development of a recombinant vaccine containing a spike S1-Fc fusion protein induced protection against MERS-CoV in human DPP4 knockin transgenic mice.
Jung BK; An Y; Park JE; Chang KS; Jang H
J Virol Methods; 2022 Jan; 299():114347. PubMed ID: 34728273
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.
Li E; Yan F; Huang P; Chi H; Xu S; Li G; Liu C; Feng N; Wang H; Zhao Y; Yang S; Xia X
Viruses; 2020 Jan; 12(1):. PubMed ID: 31968702
[TBL] [Abstract][Full Text] [Related]
19. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
[TBL] [Abstract][Full Text] [Related]
20. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.
Alharbi NK; Padron-Regalado E; Thompson CP; Kupke A; Wells D; Sloan MA; Grehan K; Temperton N; Lambe T; Warimwe G; Becker S; Hill AVS; Gilbert SC
Vaccine; 2017 Jun; 35(30):3780-3788. PubMed ID: 28579232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
